Second Sight Medical Products, Inc.
(NASDAQ : EYES)

( )
EYES PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 0.90%104.360.8%$763.44m
TMOThermo Fisher Scientific, Inc. 0.85%426.011.0%$628.17m
ISRGIntuitive Surgical, Inc. 0.00%673.732.4%$492.93m
MDTMedtronic Plc 0.98%104.200.6%$486.23m
DHRDanaher Corp. 0.01%207.180.7%$449.88m
BDXBecton, Dickinson & Co. 0.03%224.151.0%$422.13m
QDELQuidel Corp. 0.00%196.777.7%$403.46m
DXCMDexCom, Inc. 1.23%407.307.9%$323.01m
SYKStryker Corp. -0.14%204.731.3%$282.17m
BSXBoston Scientific Corp. 0.00%37.341.0%$281.37m
INOInovio Pharmaceuticals, Inc. -36.01%10.845.9%$266.30m
VARVarian Medical Systems, Inc. -0.01%171.989.1%$257.67m
BAXBaxter International, Inc. 0.01%79.651.8%$246.33m
EWEdwards Lifesciences Corp. 1.67%78.750.4%$229.79m
ALGNAlign Technology, Inc. 0.00%317.936.4%$227.19m

Company Profile

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.